Search research articles
Contact Us
Filters
Showing results (251-260 of 323) with videos related to
Page
of 33
Sort By:
European Journal of Nuclear Medicine
|
August 1, 1993
Radioimmunoscintigraphy with technetium-99m labelled monoclonal antibody, 1A3, in colorectal cancer
M Granowska, K E Britton, S J Mather, et al.
Nuclear Medicine Communications
|
March 4, 2003
123I-Interleukin-2: biochemical characterization and in vivo use for imaging autoimmune diseases
A Signore, A Picarelli, A Annovazzi, et al.
Nuclear Medicine Communications
|
October 1, 1992
A radiopharmaceutical for imaging areas of lymphocytic infiltration: 123I-interleukin-2. Labelling procedure and animal studies
A Signore, M Chianelli, A Toscano, et al.
Lancet (London, England)
|
January 27, 1996
Comparison of 99mTc infecton imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection
S Vinjamuri, A V Hall, K K Solanki, et al.
Nephron
|
January 1, 1990
The effect of ramipril, a new angiotensin-converting enzyme inhibitor on cortical nephron flow and effective renal plasma flow in patients with essential hypertension
A M al-Nahhas, C C Nimmon, K E Britton, et al.
Clinical Endocrinology
|
February 1, 1992
Pituitary imaging using a labelled somatostatin analogue in acromegaly
E Ur, S J Mather, J Bomanji, et al.
Journal of the Royal Society, Interface
|
November 11, 2025
Cell jamming transitions can affect regulatory protein gradients and prime evolutionary divergence
Alexander V Badyaev, Cody A Lee, Maxwell J Gleason, et al.
International Journal of Audiology
|
March 19, 2003
Neuro-otological findings in Pendred syndrome
L M Luxon, M Cohen, R A Coffey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 1, 1988
Technetium-99m MAG3, a comparison with iodine-123 and iodine-131 orthoiodohippurate, in patients with renal disorders
R A Jafri, K E Britton, C C Nimmon, et al.
Gynecologic Oncology
|
September 1, 1990
Radioimmunoscintigraphy of ovarian tumors using a new monoclonal antibody, SM-3
T W Jobling, M Granowska, K E Britton, et al.
Page
of 33
Search research articles
Search
Showing results (251-260 of 323) with videos related to
Sort By:
Page
of 33
European Journal of Nuclear Medicine
|
August 1, 1993
Radioimmunoscintigraphy with technetium-99m labelled monoclonal antibody, 1A3, in colorectal cancer
M Granowska, K E Britton, S J Mather, et al.
Nuclear Medicine Communications
|
March 4, 2003
123I-Interleukin-2: biochemical characterization and in vivo use for imaging autoimmune diseases
A Signore, A Picarelli, A Annovazzi, et al.
Nuclear Medicine Communications
|
October 1, 1992
A radiopharmaceutical for imaging areas of lymphocytic infiltration: 123I-interleukin-2. Labelling procedure and animal studies
A Signore, M Chianelli, A Toscano, et al.
Lancet (London, England)
|
January 27, 1996
Comparison of 99mTc infecton imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection
S Vinjamuri, A V Hall, K K Solanki, et al.
Nephron
|
January 1, 1990
The effect of ramipril, a new angiotensin-converting enzyme inhibitor on cortical nephron flow and effective renal plasma flow in patients with essential hypertension
A M al-Nahhas, C C Nimmon, K E Britton, et al.
Clinical Endocrinology
|
February 1, 1992
Pituitary imaging using a labelled somatostatin analogue in acromegaly
E Ur, S J Mather, J Bomanji, et al.
Journal of the Royal Society, Interface
|
November 11, 2025
Cell jamming transitions can affect regulatory protein gradients and prime evolutionary divergence
Alexander V Badyaev, Cody A Lee, Maxwell J Gleason, et al.
International Journal of Audiology
|
March 19, 2003
Neuro-otological findings in Pendred syndrome
L M Luxon, M Cohen, R A Coffey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 1, 1988
Technetium-99m MAG3, a comparison with iodine-123 and iodine-131 orthoiodohippurate, in patients with renal disorders
R A Jafri, K E Britton, C C Nimmon, et al.
Gynecologic Oncology
|
September 1, 1990
Radioimmunoscintigraphy of ovarian tumors using a new monoclonal antibody, SM-3
T W Jobling, M Granowska, K E Britton, et al.
Page
of 33